AU6174301A - Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity - Google Patents

Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity

Info

Publication number
AU6174301A
AU6174301A AU6174301A AU6174301A AU6174301A AU 6174301 A AU6174301 A AU 6174301A AU 6174301 A AU6174301 A AU 6174301A AU 6174301 A AU6174301 A AU 6174301A AU 6174301 A AU6174301 A AU 6174301A
Authority
AU
Australia
Prior art keywords
metastasis
activity
methods
tumor growth
reducing tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU6174301A
Inventor
William J Murphy
Joost J Oppenheim
Rosalba Salcedo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU6174301A publication Critical patent/AU6174301A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU6174301A 2000-05-19 2001-05-18 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity Pending AU6174301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20575700P 2000-05-19 2000-05-19
PCT/US2001/016058 WO2001089565A1 (en) 2000-05-19 2001-05-18 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity

Publications (1)

Publication Number Publication Date
AU6174301A true AU6174301A (en) 2001-12-03

Family

ID=22763524

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6174301A Pending AU6174301A (en) 2000-05-19 2001-05-18 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
AU2001261743A Ceased AU2001261743C9 (en) 2000-05-19 2001-05-18 Methods for reducing tumor growth and metastasis by inhibiting MCP-1 activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001261743A Ceased AU2001261743C9 (en) 2000-05-19 2001-05-18 Methods for reducing tumor growth and metastasis by inhibiting MCP-1 activity

Country Status (4)

Country Link
EP (1) EP1286698A1 (en)
AU (2) AU6174301A (en)
CA (1) CA2409298A1 (en)
WO (1) WO2001089565A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180846A1 (en) * 2001-03-01 2004-09-16 Ruo-Pan Huang Connexin enhances chemotherapy-induced apoptiosis in human cancer cells inhibiting tumor cell proliferation
EP1461300B1 (en) 2001-11-30 2011-07-27 Biogen Idec MA Inc. Antibodies against monocyte chemotactic proteins
WO2004016769A2 (en) 2002-08-19 2004-02-26 Abgenix, Inc. Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
EP1601682B1 (en) 2003-03-12 2008-05-07 Rappaport Family Institute For Research in the Medical Sciences Compositions and methods for diagnosing prostate cancer
US8017113B2 (en) 2003-03-12 2011-09-13 Rappaport Family Institute For Research In The Medical Sciences Compositions and methods for diagnosing and treating an inflammation
CA2544924A1 (en) * 2003-11-05 2005-05-19 Centocor, Inc. Methods and compositions for treating mcp-1 related pathologies
US8481035B2 (en) 2004-04-27 2013-07-09 Northwestern University Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
US7794949B2 (en) 2004-04-27 2010-09-14 Northwestern University Biomarkers of chronic pelvic pain syndrome
US8114964B2 (en) 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE232399T1 (en) * 1997-04-04 2003-02-15 Max Planck Gesellschaft METHOD FOR MODULATING THE GROWTH OF COLLATERAL ARTERIES AND/OR OTHER ARTERS FROM EXISTING ARTERIOL CONNECTIONS

Also Published As

Publication number Publication date
AU2001261743C1 (en) 2005-11-17
EP1286698A1 (en) 2003-03-05
WO2001089565A1 (en) 2001-11-29
CA2409298A1 (en) 2001-11-29
AU2001261743C9 (en) 2006-07-06
AU2001261743B2 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
AU2912902A (en) Coil for magnetic stimulation and methods for using the same
IL151781A0 (en) Methods and compositions for rna interference
AU5091201A (en) Vegf-modulated genes and methods employing them
AU4107801A (en) Alpha-amylase activity inhibitors
EP1313477A4 (en) Compounds and methods
EP1274424A4 (en) Compounds and methods
EP1333853A4 (en) Growth factor complex
DE60142323D1 (en) Halter
EP1351573A4 (en) Methods for modulating tumor growth and metastasis
GB0227147D0 (en) Magnetic stimulators and coils therefor
AU6174301A (en) Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
IL154364A0 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
GB0025312D0 (en) Methods and means for modification of plant characteristics
EP1335024A4 (en) Antibody inhibiting vplf activity
GB0012488D0 (en) Fry death rate improving system using photocatalyst
EP1343796A4 (en) Compounds and methods
GB0229613D0 (en) Biocatalyst inhibitors
AU2003297181A8 (en) Compositions and methods for inhibiting tumor growth and metastasis
AU4949901A (en) Methods for inhibiting angiogenesis and tumor growth
EP1279384A4 (en) Erogenic zone stimulator
GB0118880D0 (en) Compostions and methods for controlling molluscs
TW454506U (en) Bed structure for incubator
AU144812S (en) Bed pole
GB9923117D0 (en) Insect-paper and methods for its formation and use
TW478620U (en) Magnetic mouse-pad and mouse